Indication JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults januvia mechanism quizlet type 2 diabetes mellitus. JANUVIA is contraindicated in patients with a history of a serious hypersensitivity januvia mechanism quizlet to sitagliptin, such as anaphylaxis or angioedema. There have been postmarketing reports of acute pancreatitis, including fatal and januvia mechanism quizlet hemorrhagic or necrotizing pancreatitis, in patients taking JANUVIA.
An association between dipeptidyl peptidase-4 DPP-4 inhibitor treatment and heart failure has been observed in cardiovascular outcomes trials for two other members of the DPP-4 januvia mechanism quizlet class.
These trials evaluated patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Consider the risks and benefits /how-to-take-mobic-prednisone.html JANUVIA prior to initiating treatment in patients at risk for heart failure, such as those with quizlet prior history of heart failure and a history of renal quizlet, and observe januvia mechanism quizlet patients for signs and symptoms of heart failure during therapy.
Advise patients januvia mechanism quizlet the characteristic symptoms of heart januvia mechanism quizlet and to immediately report such symptoms.
A dosage adjustment quizlet recommended in patients januvia mechanism quizlet moderate or article source renal impairment and in patients with end-stage renal disease requiring hemodialysis or peritoneal dialysis. There have januvia mechanism quizlet postmarketing reports of worsening renal function, including acute renal failure, sometimes requiring dialysis.
A subset of these reports involved patients with renal impairment, some of whom were prescribed inappropriate doses of sitagliptin. When JANUVIA was used in combination with a sulfonylurea or insulin, medications known to cause hypoglycemia, the incidence of hypoglycemia was increased over that of placebo. januvia mechanism quizlet
Therefore, a lower dose januvia mechanism sulfonylurea quizlet insulin may be januvia mechanism quizlet to reduce the risk of hypoglycemia. The incidence and rate of hypoglycemia based on all reports of symptomatic hypoglycemia were: There have januvia mechanism postmarketing reports of serious hypersensitivity quizlet in patients treated with JANUVIA, such as anaphylaxis, angioedema, and exfoliative januvia mechanism quizlet conditions including Stevens-Johnson syndrome.
Onset of these reactions occurred within the first 3 months after initiation of treatment dosing mg celebrex quizlet JANUVIA, with some reports occurring after the first dose. If a hypersensitivity reaction is suspected, discontinue JANUVIA, assess for other potential quizlet for the event, and institute alternative quizlet for diabetes.
Angioedema has januvia mechanism been reported quizlet other DPP-4 inhibitors. There have been postmarketing reports of severe and disabling arthralgia in patients taking DPP-4 inhibitors. The time to onset of symptoms following initiation of drug therapy varied from 1 day to years.
Patients experienced relief of symptoms upon discontinuation of the medication. Januvia mechanism quizlet subset of patients experienced a recurrence of symptoms when restarting the same drug or a different DPP-4 inhibitor.
2018 ©